AC

Anvar Cherachanveettilkadavath

Director Director DIN 07970205
DIN 07970205 First appointment Sep 2019 Primary industry Education
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Anvar Cherachanveettilkadavath

Data last updated:

Anvar Cherachanveettilkadavath was a Director at Exposoft Educations Limited (2019–2021) and Director at Acorus Pharmaceuticals Private Limited (from 2019). The companies operate in Education.

DIN 07970205
Primary Designation Director
Industry Education
First Appointment 12 Sep 2019
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exposoft Educations Limited U80904KL2017PLC050886
Director12 Sep 20192017Active
Director27 Sep 20192017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acorus Pharmaceuticals Private Limited
Exposoft Educations Limited
Premium access

Shareholding and investment profile for Anvar Cherachanveettilkadavath

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anvar Cherachanveettilkadavath

Anvar Cherachanveettilkadavath was first appointed on 12 Sep 2019 as Director at Exposoft Educations Limited.

Anvar Cherachanveettilkadavath held 2 earlier board appointments: Exposoft Educations Limited (Director, 12 Sep 2019 to 09 Mar 2021); Acorus Pharmaceuticals Private Limited (Director, from 27 Sep 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available